Sponsored by
News
NHS must protect and build public’s trust in its ability to safely handle health data, report warns
Good health data, used well, can deliver real benefits for patients – improving the quality of care, reducing waiting lists, and tackling inequalities between social groups. But a new report from the Health Foundation – an independent charity – finds that government and the NHS must do more to improve public trust in how the health service handles data, as it faces public scrutiny following the award of the £330m contract for the Federated Data Platform. One of the largest surveys of public attitudes to health tech and data, carried out by Censuswide, on behalf of the Health Foundation, finds: The public largely trust NHS organisations with their data, with 69% saying that they trust GP practices, 68% local NHS hospitals and clinics, and 64% national NHS organisations. By comparison, 42% trust companies who provide the NHS with software to collect, store and use health data, and only a third trust local and national government with their health data. Over half (57%) of people aged 16-24 trust national NHS organisations with their data – but this is a significantly smaller proportion than for older people (74%). Awareness is low, with more than six in ten of the public (61%) saying they know ‘very little’ or ‘nothing at all’ about how the NHS is using the health data it collects. The public is, on balance, happy with a range of
uses of data outside the delivery of care – such as for service planning, research and the development of medicines (also known as secondary uses) –
including where the data is identifiable and being used by commercial organisations. However, many secondary uses of data are not supported by around 1 in 5 people, even with anonymisation. Public trust is critical, the report warns – without this, initiatives to harness the benefits of greater use of health data will be less likely to succeed. This is because more patients may opt out of their data being used for research and planning, meaning these data sets may be less representative, reducing the reliability of the data for the NHS and researchers. Politicians and NHS leaders should commit to a meaningful conversation with the public on the future of technology and data in healthcare, both to understand and address concerns, and to raise awareness and build confidence in the use of health technology and data, the report concludes. Given the differences
in attitudes among age groups identified by the survey, as the NHS launches its large-scale public engagement events on the use of health data next year, it will be particularly important to ensure young people are effectively represented so their concerns can be heard and influence future policy. Dr. Malte Gerhold, Director of Improvement and
Innovation at the Health Foundation, said: “Health data can deliver real benefits for patients so it’s encouraging that the public largely trust the NHS with their information. But as the use of people’s health data comes under intense public scrutiny, the NHS must work to protect and build on this existing public support for how data is used. Greater public engagement on health data can play a vital role in helping address concerns, build confidence, and ultimately improve services for patients.”
Achieve Compliance and Accuracy with Alpha Laboratories’ Third-Party Controls
The extensive range of multi-constituent controls from Alpha Laboratories helps support your laboratory’s compliance with the latest ISO 15189 quality management guidelines.
• Controls in multiple levels to test accuracy and sensitivity • Ensure confidence in reported test results • Designed to eliminate variability in test protocols
• Available to order directly or through your Managed Service Contract for even greater convenience
Body Fluids
Blood Grouping
Clinical and Immunochemistry
Haematology
Haemostasis
Don’t compromise on the quality of your diagnostic testing. Choose Alpha Laboratories for reliable and high-quality third-party controls.
For information, advice or sales enquiries please contact us: Phone 02380 483000 or email
info@alphalabs.co.uk
04 CSJ - Third Party Controls - 180x94 - Dec
2023.indd 1
www.alphalabs.co.uk 05/12/2023 09:13:49 January 2024 I
www.clinicalservicesjournal.com 13
Molecular Testing
Flow Cytometry
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64
